Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data.

MLA

Armstrong, Paul W., et al. “Efficacy and Safety of Unfractionated Heparin versus Enoxaparin: A Pooled Analysis of ASSENT-3 and -3 PLUS Data.” CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, vol. 174, no. 10, May 2006, pp. 1421–26. EBSCOhost, https://doi.org/10.1503/cmaj.051410.

APA

Armstrong, P. W., Chang, W.-C., Wallentin, L., Goldstein, P., Granger, C. B., Bogaerts, K., Danays, T., & Van de Werf, F. (2006). Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data. CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, 174(10), 1421–1426. https://doi.org/10.1503/cmaj.051410

Chicago

Armstrong, Paul W, Wei-Ching Chang, Lars Wallentin, Patrick Goldstein, Christopher B Granger, Kris Bogaerts, Thierry Danays, and Frans Van de Werf. 2006. “Efficacy and Safety of Unfractionated Heparin versus Enoxaparin: A Pooled Analysis of ASSENT-3 and -3 PLUS Data.” CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne 174 (10): 1421–26. doi:10.1503/cmaj.051410.